Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

IBB ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

IBB Analyst Ratings

Moderate Buy
233ConsensusRatings
207Buy24Hold2Sell
Based on the Wall Street analyst consensus for 233 of IBB’s holdings.

IBB 12 Month Forecast

$266.86▲(26.78% Upside)
Based on Wall Street analyst 12-month price targets for 233 of iShares Biotechnology ETF’s holdings in the last 3 months. The average price target is $266.86 with a high forecast of $358.35 and a low forecast of $188.22. The average price target represents a 26.78% change from the last price of $210.50.
Highest Price Target$358.35Average Price Target$266.86Lowest Price Target$188.22

IBB Stocks With Highest Upside Potential

IBB highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$13.00(3070.73% Upside)
Strong Buy$5.25(1029.03% Upside)
Strong Buy$14.67(810.97% Upside)
Moderate Buy$86.48(802.71% Upside)
Strong Buy$19.00(726.09% Upside)

IBB Stocks With Highest Downside Potential

IBB highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$118.13(-51.20% Downside)
Hold$3.83(-30.89% Downside)
Moderate Sell$3.00(-19.35% Downside)
Moderate Sell$8.00(-18.86% Downside)
Moderate Buy$57.00(-17.63% Downside)

IBB ETF FAQ

What is IBB’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 233 of IBB’s holdings, iShares Biotechnology ETF’s 12-month average price target is $266.86.
What is IBB’s upside potential, based on the analysts’ average price target?
IBB’s average price target of $266.86 represents a 26.78% upside from its last price of $210.50.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IBB a Buy, Sell or Hold?
iShares Biotechnology ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 233 of IBB’s holdings: 207 rated Buy, 24 rated Hold and 2 rated Sell.
What is iShares Biotechnology ETF’s price target?
The average price target for iShares Biotechnology ETF is $266.86, based on Wall Street analyst 12-month price targets for 233 of IBB’s holdings, issued in the past 3 months. The highest price target is $358.35 and the lowest is $188.22. The average price target represents a 26.78% increase from the last price of $210.50.
What do analysts say about iShares Biotechnology ETF?
iShares Biotechnology ETF’s analyst rating consensus is Moderate Buy, based on Wall Street analyst ratings for 233 of IBB’s holdings.
How can I buy shares of IBB?
You can buy shares of IBB through a brokerage account. Compare brokers on our Best Online Brokers page.